Discover · The Research Behind It
Fecal transplantation for treatment of inflammatory bowel disease — Imdad et al., Cochrane Database Syst Rev 2023
Last checked
- Free
- Worldwide
- Research paper
- Reading
- Online
- Published in
- Cochrane Database of Systematic Reviews, 2023
- Evidence
- Moderate
- Cost
- Free.
What is this paper about?
Twelve randomised trials (550 people) tested faecal microbiota transplant (FMT) for inflammatory bowel disease. In active ulcerative colitis, FMT may increase the chance of clinical remission (10 trials, 468 people; risk ratio 1.79, 95% CI 1.13 to 2.84; low-certainty evidence), with little or no difference in overall side effects. Evidence on serious harms, on keeping remission and on Crohn's disease was very uncertain.
Why is it in the directory?
Explains where faecal transplant stands for Crohn's and colitis: it may help bring active ulcerative colitis into remission (low-certainty evidence) but is unproven for Crohn's; context for the FMT listings in chapter 01, the FMT programmes and trial registries in chapter 15 and the IBD groups in chapters 06 and 15.
Is it free to read?
Cochrane systematic review and meta-analysis — 12 randomised trials, 550 adults and children with ulcerative colitis or Crohn's disease. Moderate evidence. Cochrane Database Syst Rev 2023;(4):CD012774. DOI 10.1002/14651858.CD012774.pub3. Free full text in PubMed Central (PMC10133790).
About the paper
- Authors
- Imdad A, Pandit NG, Zaman M, et al.
- Published in
- Cochrane Database Syst Rev 2023;(4):CD012774
- Kind of study
- Cochrane systematic review and meta-analysis — 12 randomised trials, 550 adults and children with ulcerative colitis or Crohn's disease
- Strength of evidence
- Moderate — good studies, but fewer of them or with some limits
- Free to read
- Free full text in PMC (Cochrane review)
Good to know
- Low-certainty evidence from small, short trials using different donors and routes; no trial tested FMT for bringing Crohn's disease into remission.
Where it sits in the directory
Listed under “The Microbiome & Chronic Disease” in chapter 17 of the directory, The Research Behind It, with 15 other listings in the same category.
Similar listings
Also in the directory, with why each one is here.
- Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry — Kelly et al., Gastroenterology 2021
Also a free research paper available worldwide, also for clinicians, listed under “Gut Health & the Gut–Brain Axis” in the same chapter.
First results from the AGA-led FMT National Registry: of 259 people given FMT for C. difficile at 20 sites, 90% of those followed for one month had resolution, 98% of…
- Effects of fecal microbiota transplantation on glycemic and lipid profiles in overweight or obese patients with metabolic disorders: a systematic review and meta-analysis — Zhang et al., Front Endocrinol (Lausanne) 2025
Also a free research paper available worldwide, also for clinicians, in the same category.
Eleven randomised trials (320 adults with overweight or obesity plus metabolic syndrome, type 2 diabetes or related problems) tested faecal microbiota transplant (FMT)…
- AGA FMT National Registry
A free tool or directory for people in the United States, also for clinicians, listed under “FMT & Microbiome Therapy” in Medical Professional Directories.
The American Gastroenterological Association's national registry for fecal microbiota transplantation (FMT) and other gut microbial therapies.
- University of Birmingham — Microbiome Treatment Centre, MHRA-licensed FMT (United Kingdom)
A free guide or book for people in the United Kingdom, also for clinicians, listed under “Regulated Microbiome Therapies” in Gut Health & the Microbiome.
The UK's first MHRA-licensed facility producing faecal microbiota transplant (FMT) under Good Manufacturing Practice, set up in 2017 inside the University of…
- TGA — Faecal microbiota transplant products: how they are regulated (Australia)
A free guide or book for people in Australia, also for clinicians, listed under “Regulated Microbiome Therapies” in Gut Health & the Microbiome.
Australia's medicines regulator explains how FMT has been regulated since 1 July 2021: most products are Class 1 (made and used in the same hospital) or Class 2 (on the…
- WHO International Clinical Trials Registry Platform — ICTRP search portal (global)
A free tool or directory available worldwide, also for clinicians, listed under “Regulated Microbiome Therapies” in Gut Health & the Microbiome.
The World Health Organization's single search point across the world's primary clinical trial registries (ANZCTR, ISRCTN, EU, Chinese, Indian, Japanese and others), so…
This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.